Metamizole
- TRADE NAMES: Algopyrin; Analgin (BPG); Baralgin; Dipyrone; Dolo-Tiaminol; Nolotil; Novalgin
- INDICATIONS: Analgesic, antipyretic, anti-inflammatory
- SYNONYM: dipyrone
- CLASS: Non-steroidal anti-inflammatory (NSAID)
- HALF-LIFE: 2–10 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.
Parenteral administration of Analgin is contraindicated in infants <1 year old.
Metamizole is banned in more than 30 countries, including Japan, Australia, the UK and the USA.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
OTHER.
Page last updated 03/01/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric